Heterogeneous Responses of Human Bone Marrow Stromal Cells (Multipotent Mesenchymal Stromal Cells) to Osteogenic Induction

[1]  Sue-Hwa Lin,et al.  Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism. , 2011, Bone.

[2]  Y. Ishii,et al.  Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. , 2010, Tissue engineering. Part A.

[3]  Y. Ishii,et al.  Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum , 2010, Growth factors.

[4]  C. Thiemermann,et al.  Mesenchymal Stromal Cells: Current Understanding and Clinical Status , 2009, Stem cells.

[5]  F. Schwarz,et al.  Guided bone regeneration using rhGDF-5- and rhBMP-2-coated natural bone mineral in rat calvarial defects. , 2009, Clinical oral implants research.

[6]  M. Harris,et al.  Recent developments in the biology of fracture repair. , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[7]  D. Prockop,et al.  Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. , 2008, Experimental hematology.

[8]  V. Salih,et al.  Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2. , 2008, The international journal of biochemistry & cell biology.

[9]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[10]  G. Reilly,et al.  Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. , 2007, Biomaterials.

[11]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  H. Woitge,et al.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts , 2002, Endocrine.

[13]  M. Swiontkowski,et al.  Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. , 2006, The Journal of bone and joint surgery. American volume.

[14]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[15]  R. Capanna,et al.  Clinical applications of BMPs. , 2005, Injury.

[16]  A. Osyczka,et al.  Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. , 2005, Endocrinology.

[17]  H. Okinaga,et al.  Glucocorticoid-induced osteoporosis. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  A. Osyczka,et al.  Different Effects of BMP-2 on Marrow Stromal Cells from Human and Rat Bone , 2004, Cells Tissues Organs.

[19]  J. Burkus,et al.  Radiographic Assessment of Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein Type 2 , 2003, Spine.

[20]  G. Reilly,et al.  BMP Responsiveness in Human Mesenchymal Stem Cells , 2003, Connective tissue research.

[21]  H. Seeherman,et al.  The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. , 2003, Journal of neurosurgery.

[22]  S. Both,et al.  Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. , 2002, Tissue engineering.

[23]  W. Lew,et al.  Osteogenic protein‐1 induced bone formation in an infected segmental defect in the rat femur , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[25]  J. Millán,et al.  Alkaline Phosphatase Knock‐Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  J. Aubin.  Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell–cell interactions in osteoblast differentiation , 1999, Journal of cellular biochemistry.

[27]  A. Reddi.  Initiation of fracture repair by bone morphogenetic proteins. , 1998, Clinical orthopaedics and related research.

[28]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[29]  F. Lecanda,et al.  Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein‐2 , 1997, Journal of cellular biochemistry.

[30]  D. Benayahu,et al.  Single‐Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  S. Kotake,et al.  Effects of recombinant human bone morphogenetic protein-2 on human bone marrow cells cultured with various biomaterials. , 1997, Journal of biomedical materials research.

[32]  S. Kadiyala,et al.  Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. , 1997, Cell transplantation.

[33]  Howard C. Tenenbaum,et al.  Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture , 1986, The Anatomical record.

[34]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[35]  J. Birkenhäger,et al.  Bone changes associated with glucocorticoid excess. , 1967, Proceedings of the Royal Society of Medicine.

[36]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.